Tactile Systems Technology Inc
NASDAQ:TCMD

Watchlist Manager
Tactile Systems Technology Inc Logo
Tactile Systems Technology Inc
NASDAQ:TCMD
Watchlist
Price: 18.33 USD -3.12% Market Closed
Market Cap: 439.9m USD
Have any thoughts about
Tactile Systems Technology Inc?
Write Note

Tactile Systems Technology Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tactile Systems Technology Inc
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Tactile Systems Technology Inc
NASDAQ:TCMD
Cash from Investing Activities
-$2.4m
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Investing Activities
-$5.5B
CAGR 3-Years
-43%
CAGR 5-Years
-49%
CAGR 10-Years
-19%
Boston Scientific Corp
NYSE:BSX
Cash from Investing Activities
-$3B
CAGR 3-Years
-33%
CAGR 5-Years
11%
CAGR 10-Years
-11%
Stryker Corp
NYSE:SYK
Cash from Investing Activities
-$2.8B
CAGR 3-Years
17%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Abbott Laboratories
NYSE:ABT
Cash from Investing Activities
-$2.3B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Investing Activities
-$3.1B
CAGR 3-Years
-12%
CAGR 5-Years
-20%
CAGR 10-Years
-72%
No Stocks Found

Tactile Systems Technology Inc
Glance View

Market Cap
439.3m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
21.22 USD
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Tactile Systems Technology Inc's Cash from Investing Activities?
Cash from Investing Activities
-2.4m USD

Based on the financial report for Jun 30, 2024, Tactile Systems Technology Inc's Cash from Investing Activities amounts to -2.4m USD.

What is Tactile Systems Technology Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
16%

Over the last year, the Cash from Investing Activities growth was 10%.

Back to Top